当前位置:BPS Bioscience Inc.>>CAR T-Cell Therapy Cell Lines>> 78186CD19 / CD20 / Firefly Luciferase CHO Cell Line
Anti-BCMA CAR /NFAT (Luciferase) Re
Anti-CD19 CAR / NFAT (Luciferase) R
Clonal stable CHO cell line constitutively expressing full length human CD19 protein (also known as CVID3, Genbank accession #NM_001770) and human CD20 protein (also known as MS4A1 and FMC7, Genbank accession #NM_021950). This cell line was derived from our CHO-K1 Luciferase cells (BPS Bioscience, #79725), therefore it also constitutively expresses the firefly luciferase reporter. Surface expression of CD19 and CD20 were confirmed by flow cytometry.
Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.
请输入账号
请输入密码
请输验证码
以上信息由企业自行提供,信息内容的真实性、准确性和合法性由相关企业负责,化工仪器网对此不承担任何保证责任。
温馨提示:为规避购买风险,建议您在购买产品前务必确认供应商资质及产品质量。